3i Diagnostics has been awarded a National Science Foundation Small Business Innovation Research (SBIR) grant for $225,000 to conduct research and development work on a solution for rapid microbial identification.
3i Diagnostics has developed a revolutionary method to RAPIDLY separate and identify any pathogen from a human blood sample with no need for culturing. Our technology is designed to help save lives by dramatically reducing the amount of time it takes to diagnose a microbial infection. 3iDx technology gives doctors the chance to improve patient outcomes by prescribing the right antibiotic at the right time.
“The National Science Foundation supports small businesses with the most innovative, cutting-edge ideas that have the potential to become great commercial successes and make huge societal impacts,” said Barry Johnson, Director of the NSF’s Division of Industrial Innovation and Partnerships. “We hope that this seed funding will spark solutions to some of the most important challenges of our time across all areas of science and technology.”
“This is a milestone event for 3iDx” said CEO Jim Janicki. “The funding from the NSF will advance our timetable for the development of the Biospectrix platform. NSF understood the breakthrough potential of our technology and has provided guidance and support to the company”.